Lost 37.5 lbs "The doctors through Willow have been wonderful." Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA
This guide walks through the seven steps I take with patients in Papillion, Omaha, and across our 16-state telehealth footprint when their Wegovy or Zepbound coverage is denied, what to ask, what to fix, what to appeal, and when to consider a different path entirely
#CagriSema #NovoNordisk #Obesity #ObesityTreatment #WeightLoss #GLP1 #Incretins #MetabolicHealth #Cardiometabolic #REDEFINE4 Novo Nordisk's CagriSema Delivers 23% Weight Loss but Misses Non-Inferiority vs Tirzepatide in REDEFINE-4 Novo Nordisk reported topline results from the Phase 3 REDEFINE-4 trial evaluating CagriSema (cagrilintide + semaglutide) in obesity
For example, A 2023 study in the New England Journal of Medicine found that semaglutide reduced the risk of death from heart disease and nonfatal heart attacks or strokes by about 20 percent for people who were obese or overweight
By accrediting bariatric surgical centers, MBSAQIP is working to advance safe, high-quality care for bariatric surgery patients
Device quality, needle depth precision, practitioner training, and protocol fidelity all determine outcomes